Non Regulatory December 28, 2023 Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment
Non Regulatory December 19, 2023 Vivesto reports positive preclinical data supporting continued development of Cantrixil
Non Regulatory August 4, 2023 Vivesto announces early termination of patient enrollment in the investigator-initiated Phase 1b Docetaxel micellar study
Non Regulatory March 20, 2023 Vivesto initiates clinical development of Paccal Vet in veterinary oncology
Non Regulatory January 11, 2023 Vivesto announces Inceptua decision to withdraw market authorization application for Apealea® in Switzerland
